Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Aerosol delivery of eukaryotic translation initiation factor 4E-binding protein 1 effectively suppresses lung tumorigenesis in K-rasLA1 mice

Abstract

Conventional radiotherapy or chemotherapy for the long-term survival of patients with lung cancer is still difficult for treatment in metastatic and advanced tumors. Therefore, the safe and effective approaches to the treatment of lung cancer are needed. In this study, the effect of delivered eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) on lung cancer progression was evaluated. Recombinant adeno-associated virus (rAAV)-M3/4E-BP1 was delivered into 6-week-old K-rasLA1 lung cancer model mice through a nose-only inhalation system twice a week for 4 weeks. Long-term repeated delivery of 4E-BP1 effectively reduced tumor progression in the lungs of K-rasLA1 mice. Reduction of eIF4E by overexpression of 4E-BP1 resulted in suppression of cap-dependent protein expression of basic fibroblast growth factor (bFGF or FGF-2) and vascular endothelial growth factor (VEGF). In addition, delivered 4E-BP1 inhibited the proliferation of lung cancer cells in K-rasLA1 mice model. Our results suggest that long-term repeated viral delivery of 4E-BP1 may provide a useful tool for designing lung cancer treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Rosell R, Gatzemeier U, Betticher DC, Keppler U, Macha HN, Pirker R et al. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Ann Oncol 2002; 13: 1539–1549.

    Article  CAS  Google Scholar 

  2. Fossella F, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, Kaukel E et al. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. J Clin Oncol 2003; 21: 3016–3024.

    Article  CAS  Google Scholar 

  3. Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004; 22: 1589–1597.

    Article  CAS  Google Scholar 

  4. Hwang SK, Lim HT, Minai-Tehrani A, Lee ES, Park J, Park SB et al. Repeated aerosol delivery of carboxyl-terminal modulator protein suppresses tumor in the lungs of K-rasLA1 mice. Am J Respir Crit Care Med 2009; 179: 1131–1140.

    Article  CAS  Google Scholar 

  5. Hong SH, Kim JE, Kim YK, Minai-Tehrani A, Shin JY, Kang B et al. Suppression of lung cancer progression by biocompatible glycerol triacrylate-spermine-mediated delivery of shAkt1. Int J Nanomedicine 2012; 7: 2293–2306.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Chang SH, Hong SH, Jiang HL, Minai-Tehrani A, Yu KN, Lee JH et al. GOLGA2/GM130, cis-golgi matrix protein, is a novel target of anticancer gene therapy. Mol Ther 2012; 20: 2052–2063.

    Article  CAS  Google Scholar 

  7. Fujimura K, Sasaki AT, Anderson P . Selenite targets eIF4E-binding protein-1 to inhibit translation initiation and induce the assembly of non-canonical stress granules. Nucleic Acids Res 2012; 40: 8099–8110.

    Article  CAS  Google Scholar 

  8. Rousseau D, Gingras AC, Pause A, Sonenberg N . The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene 1996; 13: 2415–2420.

    CAS  PubMed  Google Scholar 

  9. Kim YY, Von Weymarn L, Larsson O, Fan D, Underwood JM, Peterson MS et al. Eukaryotic initiation factor 4E binding protein family of proteins: sentinels at a translational control checkpoint in lung tumor defense. Cancer Res 2009; 69: 8455–8462.

    Article  CAS  Google Scholar 

  10. Sunavala-Dossabhoy G, Palaniyandi S, Clark C, Nathan CO, Abreo FW, Caldito G . Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer. Laryngoscope 2011; 121: 2136–2141.

    Article  CAS  Google Scholar 

  11. Jooss K, Yang Y, Fisher KJ, Wilson JM . Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol 1998; 72: 4212–4223.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Yu Y, Pilgrim P, Zhou W, Gagliano N, Frezza EE, Jenkins M et al. rAAV/Her-2/neu loading of dendritic cells for a potent cellular-mediated MHC class I restricted immune response against ovarian cancer. Viral Immunol 2008; 21: 435–442.

    Article  CAS  Google Scholar 

  13. Małecki M, Swoboda P, Pachecka J . Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells—implications for cancer gene therapy. Acta Pol Pharm 2009; 66: 93–99.

    PubMed  Google Scholar 

  14. Chen C, Sun J, Liu G, Chen J . Effect of small interference RNA targeting HIF-1alpha mediated by rAAV combined L-ascorbate on pancreatic tumors in athymic mice. Pathol Oncol Res 2009; 15: 109–114.

    Article  CAS  Google Scholar 

  15. Goula D, Becker N, Lemkine GF, Normandie P, Rodrigues J, Mantero S et al. Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene Therapy 2000; 7: 499–504.

    Article  CAS  Google Scholar 

  16. Woo JK, Choi DS, Tran HT, Gilbert BE, Hong WK, Lee HY . Liposomal encapsulation of deguelin: evidence for enhanced antitumor activity in tobacco carcinogen-induced and oncogenic K-ras-induced lung tumorigenesis. Cancer Prev Res (Phila) 2009; 2: 361–369.

    Article  CAS  Google Scholar 

  17. Wu F, Liu Y, Lv X, Miao X, Sun Y, Yu W . Small interference RNA targeting TLR4 gene effectively attenuates pulmonary inflammation in a rat model. J Biomed Biotechnol 2012; 2012: 406435.

    PubMed  PubMed Central  Google Scholar 

  18. Densmore CL . Advances in noninvasive pulmonary gene therapy. Curr Drug Deliv 2006; 3: 55–63.

    Article  CAS  Google Scholar 

  19. Beck SE, Laube BL, Barberena CI, Fischer AC, Adams RJ, Chesnut K et al. Deposition and expression of aerosolized rAAV vectors in the lungs of Rhesus macaques. Mol Ther 2002; 6: 546–554.

    Article  CAS  Google Scholar 

  20. Fischer AC, Beck SE, Smith CI, Laube BL, Askin FB, Guggino SE et al. Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques. Mol Ther 2003; 8: 918–926.

    Article  CAS  Google Scholar 

  21. Moss RB, Rodman D, Spencer LT, Aitken ML, Zeitlin PL, Waltz D et al. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest 2004; 125: 509–521.

    Article  Google Scholar 

  22. Park K, Seol W, Cho YH, Jeong S, Lee H . Cancer cell specific expression vector containing deleted mutant promoter of PRC1. Korean Pat 2010 10-2010-0007500.

  23. Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N . mTOR, translation initiation and cancer. Oncogene 2006; 25: 6416–6422.

    Article  CAS  Google Scholar 

  24. Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med 2004; 10: 484–486.

    Article  CAS  Google Scholar 

  25. Kevil CG, De Benedetti A, Payne DK, Coe LL, Laroux FS, Alexander JS . Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis. Int J Cancer 1996; 65: 785–790.

    Article  CAS  Google Scholar 

  26. Crew JP, Fuggle S, Bicknell R, Cranston DW, de Benedetti A, Harris AL . Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression. Br J Cancer 2000; 82: 161–166.

    Article  CAS  Google Scholar 

  27. Liang Z, Lei T, LuYing Z, YuPing G . The expression of proto-oncogene eIF4E in laryngeal squamous cell carcinoma. Laryngoscope 2003; 113: 1238–1243.

    Article  Google Scholar 

  28. Yang SX, Hewitt SM, Steinberg SM, Liewehr DJ, Swain SM . Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray. Oncol Rep 2007; 17: 281–287.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Part of this work was supported by the National Research Foundation grant (2012M3A9B6055304) funded by the Korea government (MEST). M-HC was also partially supported by the Research Institute for Veterinary Science, Seoul National University, Seoul, Korea.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M-H Cho.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, SH., Kim, JE., Lee, JH. et al. Aerosol delivery of eukaryotic translation initiation factor 4E-binding protein 1 effectively suppresses lung tumorigenesis in K-rasLA1 mice. Cancer Gene Ther 20, 331–335 (2013). https://doi.org/10.1038/cgt.2013.24

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2013.24

Keywords

Search

Quick links